Cargando…

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis

Accurate diagnosis of cutaneous leishmaniasis (CL) is important for chemotherapy and epidemiological studies. Common approaches for Leishmania detection involve the invasive collection of specimens for direct identification of amastigotes by microscopy and the culturing of promastigotes from infecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taslimi, Yasaman, Sadeghipour, Pardis, Habibzadeh, Sima, Mashayekhi, Vahid, Mortazavi, Hossien, Müller, Ingrid, Lane, Majella E., Kropf, Pascale, Rafati, Sima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526608/ https://www.ncbi.nlm.nih.gov/pubmed/28704463 http://dx.doi.org/10.1371/journal.pntd.0005750

Ejemplares similares

Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?
por: Taslimi, Yasaman, et al.
Publicado: (2018)

Tape-disc-loop-mediated isothermal amplification (TD-LAMP) method as noninvasive approach for diagnosis of cutaneous leishmaniasis caused by L. tropica
por: Taslimi, Yasaman, et al.
Publicado: (2023)

Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report
por: MORTAZAVI, Hossein, et al.
Publicado: (2015)

Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene Therapy
por: Taslimi, Yasaman, et al.
Publicado: (2016)

Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica
por: Masoudzadeh, Nasrin, et al.
Publicado: (2020)

Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice Model
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Biomarkers of Cutaneous Leishmaniasis
por: Bahrami, Fariborz, et al.
Publicado: (2018)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Novel strategy using live non-pathogenic Leishmania expressing selected parasite antigens as a candidate vaccine for leishmaniasis
por: Rafati, Sima, et al.
Publicado: (2011)

Comparison of Protective Potency of DNA and Live Vaccines Expressing A2-CPA-CPB(-CTE) Antigens against Visceral Leishmaniasis in Syrian Hamster as Preliminary Study
por: TASLIMI, Yasaman, et al.
Publicado: (2020)

Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae
por: Shokouhy, Mehrdad, et al.
Publicado: (2022)

Visualization of Leishmania tropica Infection in BALB/c Mice by Bioluminescence Imaging
por: Eskandar, Mahdieh, et al.
Publicado: (2020)

Live Vaccination Tactics: Possible Approaches for Controlling Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2014)

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
por: Shahbazi, Mehdi, et al.
Publicado: (2015)

Development of Novel Prime-Boost Strategies Based on a Tri-Gene Fusion Recombinant L. tarentolae Vaccine against Experimental Murine Visceral Leishmaniasis
por: Saljoughian, Noushin, et al.
Publicado: (2013)

DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Correction: DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica
por: Gholami, Elham, et al.
Publicado: (2019)

Leishmania Parasite: the Impact of New Serum-Free Medium as an Alternative for Fetal Bovine Serum
por: Habibzadeh, Sima, et al.
Publicado: (2021)

Interleukin-2 Expression in Lupoid and Usual Types of Old World Cutaneous Leishmaniasis
por: Mashayekhi Goyonlo, Vahid, et al.
Publicado: (2014)

Efficacy of Intralesional Amphotericin B for the Treatment of Cutaneous Leishmaniasis
por: Goyonlo, Vahid Mashayekhi, et al.
Publicado: (2014)

Structural analysis of PpSP15 and PsSP9 sand fly salivary proteins designed with a self-cleavable linker as a live vaccine candidate against cutaneous leishmaniasis
por: Lajevardi, Mahya Sadat, et al.
Publicado: (2022)

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression
por: Mahdavi, Maryam, et al.
Publicado: (2020)

Local Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in Ethiopia
por: Abebe, Tamrat, et al.
Publicado: (2012)

Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis
por: Caridha, Diana, et al.
Publicado: (2019)

Cutaneous leishmaniasis in a newly established treatment centre in the Lay Gayint district, Northwest Ethiopia
por: Yizengaw, Endalew, et al.
Publicado: (2023)

Leishmaniasis: Middle East and North Africa Research and Development Priorities
por: McDowell, Mary Ann, et al.
Publicado: (2011)

C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice
por: Doroud, Delaram, et al.
Publicado: (2011)

Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites
por: Badirzadeh, Alireza, et al.
Publicado: (2017)

Cutaneous Leishmaniasis Lesion on the Ear from Kashan, Central Iran: A Case Report
por: Hooshyar, Hossein, et al.
Publicado: (2023)

Human Neutrophil Peptide-1 (HNP-1): A New Anti-Leishmanial Drug Candidate
por: Dabirian, Sara, et al.
Publicado: (2013)

Plasma levels of interlukin-4 and Interferon-γ in patients with chronic or healed cutaneous leishmaniasis
por: Taheri, Ahmad Reza, et al.
Publicado: (2014)

Building Research and Development Capacity for Neglected Tropical Diseases Impacting Leishmaniasis in the Middle East and North Africa: A Case Study
por: Rafati, Sima, et al.
Publicado: (2015)

The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial
por: Tayyebi, Masoumeh, et al.
Publicado: (2021)

Antibiotic-Free Nanoplasmids as Promising Alternatives for Conventional DNA Vectors
por: Seyed, Negar, et al.
Publicado: (2022)

Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice
por: Abdossamadi, Zahra, et al.
Publicado: (2017)

Nutritional Intake and Chronicity Associated with the Old World Cutaneous Leishmaniasis: Role of Vitamin A
por: MASHAYEKHI GOYONLO, Vahid, et al.
Publicado: (2020)

Age-Related Alteration of Arginase Activity Impacts on Severity of Leishmaniasis
por: Müller, Ingrid, et al.
Publicado: (2008)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen
por: Zahedifard, Farnaz, et al.
Publicado: (2014)

Reactivation of Cutaneous Leishmaniasis after Renal Transplantation: A Case Report
por: Mortazavi, Hossein, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e72a0kpmf2thbu73468dpoinot